True Private Wealth Advisors Compugen LTD Transaction History

True Private Wealth Advisors

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Oct 18, 2018	SELL	$3.0 - $4.05 $43,092 - $58,174	-14,364 Closed	0 $0
Q2 2018 Jul 13, 2018	BUY	$3.15 - $4.7 $3,150 - $4,700	1,000 Added 7.48%	14,364 $47,000
Q1 2018 Apr 25, 2018	BUY	$2.5 - $4.45 $33,410 - $59,469	13,364 New	13,364 $59,000

13.1M

79.2K

12.7K

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $131M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

Get notified when there are updates to the investment portfolio of True Private Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on True Private Wealth Advisors with notifications on news.